Indian Scientists Find Genetic Switch for Pregnancy
Indian researchers discover how HOXA10 and TWIST2 genes regulate embryo implantation. This breakthrough could transform fertility treatments and pregnancy success rates.
Indian researchers discover how HOXA10 and TWIST2 genes regulate embryo implantation. This breakthrough could transform fertility treatments and pregnancy success rates.
Indian scientists develop indigenous gene editing therapy Birsa-101 for sickle cell disease, set to make treatment affordable with clinical trials starting next year.
ICAR patents indigenous TnpB gene editing technology, offering a miniature alternative to CRISPR. This breakthrough promises cheaper, IP-free GE crop development for Indian farmers.
Groundbreaking study using AI reveals how NOD2 gene mutations disrupt gut immune balance, causing Crohn's disease inflammation. Discover the molecular battlefield in your gut.
Discover how maternal nutrition during pregnancy directly impacts your baby's genetic development and long-term health. Learn essential dietary guidelines for expectant mothers.
Indian vaccine maker Bharat Biotech expands into high-growth CRDMO space with new subsidiary Nucelion Therapeutics, focusing on cutting-edge cell and gene therapies for cancer and rare diseases.
In a significant setback for gene editing medicine, Intellia Therapeutics halts its Phase 3 ATTR trial following a serious liver adverse event in a patient receiving CRISPR-based treatment NZ-1.
India's health ministry introduces strict new regulations for gene therapy and stem cell treatments, aiming to curb unproven medical procedures while advancing legitimate research for conditions like cancer and rare diseases.